CPT code 83690 represents a laboratory assay that measures lipase, a pancreatic enzyme essential for fat digestion. Nationally, lipase testing is a common diagnostic tool used in emergency departments, inpatient wards, and outpatient laboratories to evaluate suspected acute pancreatitis, monitor pancreatic disease, and guide clinical management. Accurate coding for lipase assays supports appropriate laboratory billing and clinical recordkeeping across care settings.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context, common sites of service, and the typical laboratory service type. The publication also provides benchmarking and payer coverage context, discussion of common modifier usage where applicable, and implications for coding workflows and claims processing. While clinical interpretation remains with treating clinicians, the content clarifies billing semantics and operational considerations relevant to laboratories, hospital billing offices, and revenue cycle teams.